# supply chain compliance

China’s Drug Regulator Flags 50 Batches of Unsafe Cosmetics, Orders Local Probes and Sales Bans

China’s drug regulator has identified 50 batches of cosmetics that failed 2025 national sampling tests for issues including microbial contamination, excessive acrylamide and mismatches between labelled and detected sunscreen ingredients. Provincial regulators have been ordered to investigate manufacturers and registrants, halt sales and pursue legal accountability where warranted. The move underscores Beijing’s sustained push for tighter cosmetics oversight and raises compliance, reputational and commercial stakes for domestic and foreign brands.